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Abstract
Introduction Pharmacovigilance, the monitoring of drug
safety after marketing approval, highly depends on the
adequate reporting of adverse drug reactions (ADRs). To
improve pharmacovigilance awareness and future ADR
reporting among medical students, we developed and
evaluated a student-run pharmacovigilance programme.
Methods In this project, teams of medical students (first- to
fifth-year) assessed real ADR reports, as submitted to the
national pharmacovigilance centre. After assessment of
causality, including identification of a potential pharma-
cological explanation for the ADR, the students wrote a
personalized feedback letter to the reporter, as well as a
summary for the European Medicines Agency (EMA) and
World Health Organization (WHO) pharmacovigilance
databases. This student assessment was then verified and
evaluated by staff from The Netherlands Pharmacovigi-
lance Centre Lareb (Lareb), using an e-questionnaire.
Student attitudes, intentions, skills, and knowledge of ADR
reporting were evaluated using the e-questionnaire, before
and after participation in the programme.
Results From May 2014 to January 2015, a total of 43 stu-
dents assessed 100 different ADR reports selected by Lareb
staff (n = 3). Student assessmentswere rated as useful (93%),
scientifically substantiated (90%), accurate (92%), and com-
plete (92%), and, on average, did not cost Lareb staff extra
time. Medical students were positive about ADR reporting,
and their awareness of ADR reporting increased significantly
following participation in the programme (p\ 0.05). After
participation in the programme, the students intended to report
serious ADRs in their future practice, and their knowledge of
pharmacovigilance and ADR reporting showed they had a
high overall level of pharmacological understanding.
Conclusion The student-run pharmacovigilance pro-
gramme is a win–win venture. It offers students a valuable
‘pharmacovigilance experience’, creates awareness in
future doctors, and has the potential to increase pharma-
covigilance skills and knowledge.
Key Points
The student-run pharmacovigilance programme has
mutual benefits for students and pharmacovigilance.
Undergraduate medical students can make useful,
scientifically substantiated, accurate, and complete
assessments of adverse drug reaction (ADR) reports.
Participating students were positive about ADR
reporting, their awareness of ADR reporting increased,
and they would likely report ADRs in the future.
Electronic supplementary material The online version of this
article (doi:10.1007/s40264-016-0502-1) contains supplementary
material, which is available to authorized users.
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Annually, millions of patients experience an adverse drug
reaction (ADR) and, with the increasing use of medicinal
drugs, the number of ADRs is also increasing [1]. ADRs
can range from minor harm to full anaphylaxis, and even
death, and may cause hospital admission, patient burden,
and additional costs [1–4]. Although drug registration
protocols require sound (pre)clinical testing of the safety
and ADRs of new drugs, relatively little is known about
these aspects in real-life circumstances prior to the drugs
being given marketing approval [1, 3]. The monitor-
ing/surveillance of ADRs after marketing approval (phar-
macovigilance) is essential for identifying previously
undetected, uncommon, or serious ADRs, and for
improving understanding of drug risk profiles and medi-
cation safety [5, 6].
Pharmacovigilance centres play a major role in the
postmarketing monitoring of drug safety, which, in many
countries, is based on spontaneous (or voluntary) reporting
[7]. Clinical observations, from both patients and health-
care professionals, serve as a starting point for reporting
suspected ADRs. Most reported suspected ADRs are
reported by health professionals, but also by patients [7],
which means that health professionals should have suffi-
cient knowledge, adequate abilities, and a positive attitude
to evaluating and reporting possible ADRs encountered in
daily practice. They are encouraged, and in some countries
legally obliged, to report serious and unknown ADRs to the
competent authority [8, 9]. Although ADR reporting is a
professional responsibility, the rate of underreporting is
high and this hinders optimal ADR monitoring [7, 10, 11].
Previous studies have identified multiple factors as under-
lying the low level of ADR reporting: indifference, lack of
motivation, lack of knowledge, negative attitudes, mis-
conceptions, and difficulty in accessing forms [11].
While medical and pharmacy students recognize the
importance of ADR reporting and express the intention to
report ADRs [12, 13], they are insufficiently prepared to
handle ADRs and have inadequate pharmacovigilance
skills and knowledge [12–14]. This may hamper optimal
patient care and the safe use of drugs. Thus, there is a need
to raise awareness, knowledge, and skills in recognizing,
managing and reporting ADRs. While several interventions
have proven effective for practising health professionals
[3, 15], only a few interventions focus on future health
professionals, such as medical or pharmacy students
[15–17]. Most of these interventions have a theoretical
basis (lectures), whereas students have indicated that they
prefer active forms of learning [12–14]. Among trainee
general practitioners, a practice-based method led to more
and better documented ADR reports than a lecture-based
approach [18]. Such exposure and practice are known to be
necessary to master clinical skills: ‘practice makes perfect’
[19].
A practice-based and innovative approach for medical
students could be the learner-centred student-run clinic
(LC-SRC), which is based on the conceptual framework of
‘learning by doing’ [20]. In the LC-SRC, medical students
get the opportunity and responsibility to contribute to a real
clinical task, such as a consultation with a patient [21]. In
this way, they practice clinical skills (such as prescribing)
in a real context-based situation as early as possible in their
medical education [22]. To meet students’ wishes for an
active learning approach, we postulated that a pharma-
covigilance project within the existing LC-SRC would
facilitate the development of students’ pharmacovigilance
attitudes, knowledge and skills in recognizing, managing,
and reporting ADRs in real-life clinical practice.
The aim of this project was to increase the pharma-
covigilance awareness and skills of medical students so
that they would recognize and be able to manage and report
ADRs in their future practice. The primary objectives were
to analyse (1) the feasibility of the LC-SRC pharma-
covigilance programme, and (2) the educational value of
such a programme in terms of students’ pharmacovigilance
skills and knowledge.
2 Methods
This prospective cohort study involved the Pharmacother-
apy Section, Department of Internal Medicine, VU
University Medical Center (VUmc), Amsterdam, The
Netherlands, and The Netherlands Pharmacovigilance
Centre Lareb (Lareb). Lareb is responsible for the collec-
tion and analysis of ADRs to medicines and vaccines, and
for education on medication safety in The Netherlands. The
pharmacovigilance programme was set up in April 2014 as
an initiative within the LC-SRC of the VUmc. The overall
aim of the LC-SRC is to improve undergraduate pharma-
cotherapy education [22].
2.1 Setting
From May 2014 to January 2015, the LC-SRC received
three anonymized ADR reports from Lareb on a weekly
basis. The reports had been selected (by Lareb staff) for
their suitability regarding adequate documentation, rele-
vance, and potential underlying pharmacological mecha-
nism. This selection was in accordance with the
educational aim of the project. The LC-SRC project was
coordinated by students with experience in the LC-SRC
who volunteered to take on a coordinating role. These
coordinators added information, including a students’
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manual, step-by-step assessment form, and additional
database information. Furthermore, they gave guidance and
made weekly appointments with the student teams (three to
six participants) to provide feedback (see Fig. 1). Student
teams had 6–10 days to assess the causality of the ADR,
study the potential pharmacological mechanism, write a
personalized feedback letter to the ADR reporter, and write
a summary for the pharmacovigilance databases of the
European Medicines Agency (EMA) and World Health
Organization (WHO). Students were allowed to use any
resource (e.g. summary of product characteristics (SmPC),
Uptodate, Micromedex, which are regularly used by the
Lareb assessors). After a final evaluation, the student
coordinator mailed the final ADR assessment to an assessor
at Lareb, where the assessment and concept feedback letter
were reviewed. Th eLareb assessor also provided feedback
on the assessment and sent the final feedback letter to
students to optimize learning.
2.2 Population
First- to fifth-year medical students of the VUmc School of
Medical Sciences who participated in the LC-SRC
(n = ±80) were eligible for this extracurricular pharma-
covigilance programme.
2.3 Evaluation Instruments
The student-run pharmacovigilance programme was con-
sidered feasible if (1) the quality of the student assessments
was acceptable; (2) the time it took to supervise was rea-
sonable; and (3) the project had positive effects on students
(which was assessed together with educational value). The
feasibility of the LC-SRC pharmacovigilance programme
and its educational value were evaluated using three dif-
ferent e-questionnaires: students completed one question-
naire before participation in the programme and another
after participation, while Lareb staff completed one ques-
tionnaire after verification of each ADR assessment. The
three questionnaires are available in Electronic Supple-
mentary Material 1.
2.3.1 Lareb Supervisor E-questionnaire
Lareb staff were asked to fill in a short (2 min, six ques-
tions) e-questionnaire after they verified each ADR
assessment. Assessments were rated for completeness,
substantiation, inaccuracies, and time it took to verify the
student ADR assessment, compared with the time it would
take the staff member to deal with the ADR report them-
selves. Lastly, the final assessment was graded (scores
1–10, minimum–maximum). This questionnaire was com-
posed of closed and multiple-choice questions (5-point
Likert scales) and there was room for feedback.
2.3.2 Student Pre-Participation E-Questionnaire
Students completed a short (2–3 min, six questions)
e-questionnaire to assess their familiarity with pharma-
covigilance and ADR reporting prior to taking part in the
programme. Besides providing information about their
characteristics (student number, sex, study year), students
also answered an open question about how they would
manage a suspected ADR. Closed questions were asked
relating to their awareness of ADRs and ADR reporting.
2.3.3 Student Post-Participation E-Questionnaire
After participation in the programme, students completed a
more detailed (10 min, 15 questions) e-questionnaire to
assess their role and progress in ADR management and
their opinion about their pharmacovigilance training and
the student-run pharmacovigilance programme. The ques-
tionnaire also focused on student attitudes and intentions
regarding ADR reporting. These multiple-choice questions
(7-point Likert scale) were based on the Dutch national
pharmacovigilance study [12] and the studies of Gavaza
et al. [13, 23, 24]. As in the national study [12], open-ended
and dichotomous questions were used to investigate stu-
dents’ knowledge and skills regarding basic pharma-
covigilance and ADR reporting. Additional open-ended
questions relating to pharmacovigilance knowledge were
added: ‘‘What is the meaning of the black triangle on the
packaging of medications?’’; ‘‘Which resources can you
use to see if an ADR is known?’’; ‘‘What does a positive
de- or re-challenge mean?’’; and ‘‘Which patient-related
factors could play a role in the development of an ADR?’’
Patient or health professional
Netherlands Pharmacovigilance Center Lareb
Student coordinator pharmacovigilance programme






Fig. 1 Handling of ADR reports. 1 Health professional or patient
reports ADR to The Netherlands Pharmacovigilance Centre Lareb; 2
Lareb staff send ADR reports to the student coordinator of the
pharmacovigilance programme; 3 Student coordinator sends report to
student teams who assess the ADR report; 4 Student coordinator
supports and gives feedback on ADR assessment; 5 Students send
concept assessment to student coordinator; 6 Student coordinator
sends final assessment to Lareb; 7 Lareb staff verify and score ADR
assessments, submit report, and send feedback letter to the health
professional or patient. ADR adverse drug reaction
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2.4 Data Analysis
Data were analysed using SPSS Statistics 22 (IBM Cor-
poration, Armonk, NY, USA). Descriptive statistics were
computed for the student and supervisor populations,
assessment rating, and student outcomes. Student outcomes
were analysed based on the levels of Kirkpatrick’s hierar-
chy [25] and were divided into three groups: intentions/
attitudes, knowledge and skills of ADR reporting. Student
open-ended questions were analysed using content/the-
matic analysis, and student responses on the questions in
both the pre- and post-questionnaire (where, why, and what
to report, and what they would do if they encountered an
ADR) were analysed using a generalized estimating
equation (GEE) analysis to test if participation in the pro-
gramme improved pharmacovigilance skills and knowl-
edge. The GEE analysis has several advantages compared
with a repeated measures t test (e.g. homogeneity of vari-
ance is not necessary and no loss of information when parts
of the longitudinal data are missing). Results of changes in
responses (pre–post) are displayed in absolute differences
(%). A one-way analysis of variance (ANOVA) was used
to compare the mean intention scores for reporting in three
different situations (serious, unknown, and all ADRs). A
significance level with an a of 5% was considered statis-
tically significant (p\ 0.05) for all analyses.
2.5 Ethical Aspects
All ADR reporters agreed to the Lareb privacy statement
(http://www.lareb.nl/Footer/Privacy), and the ADR reports
were anonymously forwarded to students by Lareb staff.
The Institutional Review Board (IRB) of the VUmc
reviewed the research protocol and concluded that the
study did not fall under the scope of the Dutch Medical
Research Involving Human Subjects Act (WMO) [refer-
ence 15348). Participation in the pharmacovigilance pro-
gramme was voluntary, and students, coordinators, and
Lareb supervisors did not receive any form of credit,
payment, or incentive. All students gave informed consent
to participate in this study and for using the e-question-
naires for scientific purposes.
3 Results
In total, 100 ADR reports were assessed by 43 medical
students working in teams. The students assessed 1–10
(mean 2.9, standard deviation [SD] 2.7) ADR reports.
Eighty-seven reports originated from healthcare providers
and 13 originated from patients. In total, 115 drugs were
mentioned; antidepressants (16%) and antibiotics (11%)
were the main drug groups reported. Sixty-two percent of
the suspect drugs were non-essential drugs, defined as not
being included in the 19th WHO essential medicine list
[26]. The ADR reports mentioned 148 different symptoms;
neurological (13%) and psychological (12%) symptoms
were the most commonly reported events.
All student assessments of the ADR reports were
remotely supervised and evaluated by Lareb staff (n = 3)
using an e-questionnaire (see Table 1). They rated the
assessments as being useful/very useful in 93% of cases
(mean 4.58, SD 0.65), scientifically substantiated in 90% of
cases (mean 4.49, SD 0.73), and complete (as in ‘not
lacking important information’) in 92% of cases; 92% of
the reports did not contain inaccuracies. The overall
assessment was scored 8.29 (SD 1.15) out of 10 (maxi-
mum). The Lareb staff indicated that the student assess-
ments saved time in 33% of cases, were time neutral in
56% of cases, and cost them extra time in 11% of cases.
3.1 Student Outcomes—Skills and Knowledge
(Longitudinal Study)
A total of 29 (67.5%) participants completed the e-ques-
tionnaire before and after participation in the programme.
The characteristics of study participants are available in
Electronic Supplementary Material 2. Before participation
in the programme, most students (89.7%) were aware of
the reasons for ADR reporting, although only 62.1% of
students knew where to report ADRs, and fewer (27.6%)
knew what information was needed to fill in the ADR
report. After participation in the pharmacovigilance pro-
gramme, students were better informed as to where to
report ADRs (?37.9%; p\ 0.05) and what was needed for
a qualitatively good report (?55.2%; p\ 0.05). More
students knew why ADRs should be reported to Lareb,
however this improvement was statistically non-significant
(?6.9%; p[ 0.05) [see Fig. 2].
How students responded to anADR in one of their patients
did not change significantly after participation in the pro-
gramme. In Table 2, the specific actions students suggested
to take before and after participation are displayed.
3.2 Student Outcomes (Post-Participation)
3.2.1 Intentions
After participation in the programme, all students (n = 29)
intended to report serious (mean 6.38, SD 0.73) and
unknown ADRs (mean 6.31, SD 0.81), but were less pre-
pared (one-way ANOVA; p\ 0.05) to report all ADRs
encountered (mean 2.93, SD 1.22) to the competent
authority. Six students (21%) had already reported at least
one ADR to Lareb. Student intentions towards ADR
reporting in different situations are displayed in Table 3.
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3.2.2 Attitudes
Students had a high score for attitude relating to reporting
ADRs after participation in the programme, and students
rated ‘contributing to medication safety’ (mean 6.31, SD
0.66, 7-point Likert scale) as the main reason to report
ADRs. ‘Improving patient safety’ (mean 6.21, SD 0.77)
and ‘educating others about drug risks’ (mean 5.93, SD
0.92) were also important reasons. Students did not believe
reporting ADRs could ‘break trust with patients’ (mean
2.14, SD 0.74) or ‘increase the risk of malpractice’ (mean
2.72, SD 1.33). Student attitudes towards ADR reporting in
different situations are displayed in Table 3.
3.2.3 Knowledge and Skills
After they had participated in the programme, over three-
quarters (82.8%) of students knew which items are neces-
sary for a qualitatively good ADR report (scores for stu-
dents’ skills and knowledge tests are available in Electronic
Supplementary Material 2). Comedication (72.4%), a
description of the reported ADR[s] (62.1%), and patient
information (age and sex) and history (both 48.3%) were the
most frequently mentioned essential items. Students were
familiar with the resources they could consult if they
encountered an ADR, and mentioned the SmPC (60.7%),
Farmacotherapeutisch Kompas [Dutch independent medi-
cation information system for health professionals] (57.1%),
and the website of Lareb (50%). Micromedex, PubMed,
and other resources (e.g. books and Up-to-date) were
mentioned less frequently (14.3, 28.6, and 7.1%, respec-
tively). Students had a mean score for knowledge of general
pharmacovigilance of 82.5% for dichotomous questions,
uncorrected for guessing, and 53.5% for open questions. The
items with the highest scores were the reporter’s identity and
the necessity of reporting, even if all relevant information
was not available. Incorrect answers were most often given
to the questions relating to understanding of the term
‘pharmacovigilance’ and the explanation of a ‘de-challenge
or re-challenge’. After participation in the programme,
75.9% of students knew that patients and/or medical stu-
dents could report ADRs (even during their clerkships)
(Electronic Supplementary Material 2).
Table 1 Rating of student assessments by Lareb staff
Assessment rating N Mean (SD) Fully disagree – Neutral – Fully agree
Useful assessment 100 4.58 (0.65) – 1 6 27 66
Scientifically substantiated assessment 100 4.49 (0.73) – 2 8 29 61
Less time – Neutral – More time
Time spent verifying the student ADR
assessment, compared with self-
handling
100 2.78 (0.77) 3 30 56 8 3




Total assessment rating 100 8.29 (1.15) 2 16 82
Yes No
Assessment was accurate 100 – 92 8
Assessment was complete 100 – 92 8
SD standard deviation, ADR adverse drug reaction
Fig. 2 Student responses to where, what, and why report a suspected
ADR pre- and post-participation in the student-run pharmacovigilance
programme. ADR adverse drug reaction, n.s. non-statistically signif-
icant difference, *indicates statistically significant difference
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3.2.4 Students’ Reflections on Participating
Overall, students valued the pharmacovigilance pro-
gramme. They responded to having learned skills such as
performing an ADR assessment (n = 10) and searching
and assessing scientific literature (n = 9) in response to the
open question relating to what they had learned by par-
ticipating in the programme (see Table 4). Other subjects
they reported to have learned included the importance of
reporting ADRs (n = 7) and general pharmacological
knowledge (n = 6). Students found assessing ADR reports
educational (mean 4.33, SD 0.88), more instructive than
fictive casuistry (mean 4.22, SD 0.70), and felt responsible
for assessing the ADR reports (mean 4.22, SD 0.80). They
did not consider that their current curriculum covered
pharmacovigilance well (mean 2.70, SD 1.03) and thought
that more pharmacovigilance education was needed (mean
3.96, SD 0.94). They thought that assessing ADR reports
should be included in their curriculum (mean 3.93, SD
0.78).
4 Discussion
This study shows that undergraduate medical students can
make high-quality (useful, scientifically substantiated,
accurate, and complete) assessments of ADR reports,
without costing Lareb staff extra time. Moreover, the
programme improved the pharmacovigilance skills and
awareness of future health professionals and provided the
opportunity to give instruction on basic and clinical phar-
macovigilance skills and knowledge. The programme gives
undergraduate medical students the unique opportunity to
participate in real pharmacovigilance practice. Therefore,
the feasibility criteria were met and the student-run phar-
macovigilance programme appears to be a win–win ven-
ture for both Lareb and medical students.
It is surprising that the medical students provided such
high-quality assessment because ADRs are perceived as a
difficult subject in pharmacotherapy practice and educa-
tion. There are no previous studies of students contributing
to pharmacovigilance by assessing ADR reports, therefore
Table 2 Student-acquired skills and knowledge (longitudinal)
Participants indicating ‘‘I know
where (in The Netherlands) to
report an ADR’’ [% (n)]
Participants indicating ‘‘I know which
essential information is needed for a
qualitatively good ADR report’’ [% (n)]
Participants indicating ‘‘I know why
ADRs should be reported to The
Netherlands Pharmacovigilance Centre
Lareb’’ [% (n)]
Pre- Post- Pre- Post- Pre- Post-
Student responses to where, what, and why report a suspected ADR
First year (B1) 42.9 (3/7) 100 (2/2) 0 (0/7) 50 (1/2) 100 (7/7) 100 (2/2)
Second year (B2) 33.3 (2/6) 100 (7/7) 33.3 (2/6) 71.4 (5/7) 66.7 (4/6) 100 (7/7)
Third year (B3) 78.6 (11/14) 100 (12/12) 28.6 (4/14) 83.3 (10/12) 92.9 (13/14) 91.7 (11/12)
Fourth year (M1) 100 (2/2) 100 (7/7) 100 (2/2) 100 (7/7) 100 (2/2) 100 (7/7)
Fifth year (M2) – 100 (1/1) – 100 (1/1) – 100 (1/1)
Total 62.1 (18/29) 100 (29/29)a 27.6 (8/29) 82.8 (24/29)a 89.7 (26/29) 96.6 (28/29)
Pre [n = 29] (%) Post [n = 29] (%) p-value (95% CI)
Student responses when encountering an ADR
Search for additional information 62.1 76.7 0.115 (0.850–4.480)
Search for an alternative drug 27.6 30.0 0.818 (0.259–2.909)
Discontinuing the suspected drug 24.1 20.0 0.957 (0.258–3.278)
Altering (lower) dose of suspected drug 17.2 10.0 0.224 (0.657–5.992)
Depends on severity/indication 20.6 10.0 0.504 (0.167–1.522)
Report to pharmacovigilance centre 31.0 43.3 0.317 (0.202–1.680)
Communication with patient 3.4 6.7 0.548 (0.046–5.139)
Upper part: Student skills and knowledge to adequately report a suspected ADR
Lower part: Student responses when encountering an ADR and GEE analysis outcome of statistical difference
ADR adverse drug reaction, GEE generalized estimating equation
a Statistical significance between pre- and post-participation
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we could not compare our findings with those of other
studies. However, in an earlier study, undergraduate stu-
dents were able to solve difficult pharmacotherapy prob-
lems and performed at junior doctor level in an LC-SRC
[21], which might be attributable to students responding
well to the opportunity and responsibility of contributing to
a real clinical task early in their medical education,
showing greater intrinsic motivation and willingness to
invest time and energy voluntarily [27, 28].
In general, supervising the student assessments, com-
prising selection of useful reports for the programme, and
rephrasing feedback letters to professional communication
cost little extra time compared with a full assessment by
Lareb staff themselves. This is an essential finding because
it helps to secure the future of this project and is an
important condition for the win–win venture between stu-
dents and Lareb. Only 11% of the ADR reports cost Lareb
staff extra time, but this was not because the reports were
of poor quality but because the extensive and in-depth
reports prepared by the students necessitated Lareb staff
taking extra time to check the additional referenced liter-
ature/resources. These reports were awarded high marks
(data not shown).
The programme raised the pharmacovigilance aware-
ness of future health professionals, an essential aspect of
rational prescribing and medication safety. Nearly all
participating students knew where, why, and what was
needed for a qualitatively good report. Compared with
earlier studies, students participating in our programme had
a more positive attitude towards reporting serious and
unknown ADRs and had higher intention scores than
pharmacists, and pharmacy and medical students
[12, 13, 23]. Potential negative aspects of ADR reporting,
such as ‘disrupting the normal workflow’ and ‘time con-
suming to report’, were considered less likely. Students
mentioned important items needed for a qualitatively good
report more often, and had higher scores for basic phar-
macovigilance knowledge than in an earlier study [12].
Most earlier interventions to raise awareness of ADR
reporting predominantly targeted health professionals and
were passive (reminders, lectures, etc.) instead of active
educational interventions [15]. Furthermore, the main
outcomes used consisted of the number of spontaneous
reports, which is an intermediate outcome because it does
not consider the additional value of the reports for phar-
macovigilance (quality, novelty, etc.). Interventions for
pharmacy students used lectures or other theoretical means
and not contemporary educational interventions [16]. The
current study was based on the conceptual framework of
‘learning by doing’ [20] and incorporated educational
theory to improve pharmacovigilance teaching and prac-
tice, and measured relevant and direct outcomes.
Table 3 Students’ intentions and attitudes to reporting ADRs
N Mean (SD) Extremely unlikely (%) Neither likely nor unlikely (%) Extremely
likely (%)
1 2 3 4 5 6 7
Intentions and attitudes towards ADR reporting
I intend to report serious ADRs that I
encounter to the competent authority
29 6.38 (0.73) – – – – 4 (13.8) 10 (34.5) 15 (51.7)
I intend to report unknown ADRs that I
encounter to the competent authority
29 6.31 (0.81) – – – 1 (3.4) 3 (10.3) 11 (37.9) 14 (48.3)
I intend to report all ADRs that I
encounter to the competent authority
29 2.93a (1.22) 3 (10.3) 8 (27.6) 10 (34.5) 5 (17.2) 2 (6.9) 1 (3.4) –
How likely do you think the following outcomes will be if you report an ADR?
Contributes to the safe use of
medicines
29 6.31 (0.66) – – – – 3 (10.3) 14 (48.3) 12 (41.4)
Improves patient safety 29 6.21 (0.77) – – – – 6 (20.7) 11 (37.9) 12 (41.4)
Educates others about drug risks 29 5.93 (0.92) – – – 1 (3.4) 10 (34.5) 8 (27.6) 10 (34.5)
Personally beneficial 29 4.14 (1.68) 1 (3.4) 6 (20.7) 2 (6.9) 8 (27.6) 6 (20.7) 3 (10.3) 3 (10.3)
Time consuming to report 29 4.00 (1.67) 3 (10.3) 2 (6.9) 5 (17.2) 9 (31.0) 4 (13.8) 4 (13.8) 2 (6.9)
Disrupts the normal workflow 29 3.83 (1.63) 2 (6.9) 7 (24.1) 2 (6.9) 5 (17.2) 10 (34.5) 2 (6.9) 1 (3.4)
Increases risk of malpractice 29 2.72 (1.33) 2 (6.9) 16 (55.2) 4 (13.8) 4 (13.8) 2 (6.9) – 1 (3.4)
Breaks trust with patients 29 2.14 (0.74) 5 (17.2) 16 (55.2) 7 (24.1) 1 (3.4) – – –
Upper part: Student intentions to report serious, unknown and all encountered ADRs to the competent authority
Lower part: Student behaviour beliefs towards reporting an ADR
ADR adverse drug reaction, SD standard deviation
a Statistical significant difference
Feasibility and Educational Value of a Student-Run PV Programme
The strength of this study lies in the unique collabora-
tion with Lareb, whereby real and legitimate ADRs could
be assessed and used for educational purposes while con-
tributing to the monitoring of real ADRs. The use of pre-
viously published questionnaires [12, 13, 23, 24] on ADR
reporting allowed us to compare the intentions, attitudes,
knowledge, and ADR handling capability of future health
professionals. The use of pre- and post-participation
questionnaires enabled us to investigate educational values
and to monitor student progress in this longitudinal study
design.
The major limitations of this study are the relatively
small heterogeneous sample size (43 students) and the
response rate (67.5%) for the questionnaires, both of which
limited study power. Furthermore, self-selection bias
played a role since only students who had voluntarily
participated in the LC-SRC were eligible to participate in
the pharmacovigilance programme. Students who partici-
pated were probably more interested in the topic, having a
greater interest in pharmacotherapy. Thus, we may have
gained an overpositive impression of the general medical
student population. The concept of the student-run phar-
macovigilance programme and the presented results would
be of interest to other universities and to other countries
where pharmacovigilance centres play a similar role as in
The Netherlands. As a WHO collaborating centre in
pharmacovigilance education, Lareb plays an important
role in developing, testing, distributing, and sharing inno-
vative and successful educational methods [29].
5 Conclusions
Undergraduate medical students can make high-quality
(useful, scientifically substantiated, accurate, and com-
plete) assessments of ADR reports, and that making such
assessments increases the pharmacovigilance awareness of
students. Thus, a student-run pharmacovigilance pro-
gramme is feasible and a win–win venture for Lareb and
medical students. This study contributed to insight into the
intentions, skills, and knowledge of pharmacovigilance and
ADRs of undergraduate medical students by providing a
unique opportunity to participate in real pharmacovigilance
practice. This study also showed that students valued the
extra attention paid to pharmacovigilance and would prefer
to have more real-life practice in their medical curriculum.
Further research is needed to determine the additional
value of this novel approach, compared with, for instance,
Table 4 Quotations/statements by participating students regarding what they learned in response to the open question ‘‘What have you learned
by participating in the student-run pharmacovigilance programme? [See Electronic Supplementary Material 1]
Theme Quotations
Intentions and attitudes
Importance of reporting (n = 7) ‘‘That a lot is learned about medication by reporting ADRs’’
‘‘The importance of reporting ADRs and assessing them properly’’
Pharmacovigilant attitude (n = 2) ‘‘To better look at the medications patients are using. Many new patient complaints
could be better explained by adverse drug reactions instead of a new diagnosis’’
Knowledge
Pharmacological knowledge (n = 6) ‘‘The existence of dangerous interactions between certain drugs’’
‘‘Additional pharmacological knowledge and knowledge regarding the specific
mechanism of action in the ADR reports I assessed’’
Knowledge regarding ADRs (n = 4) ‘‘I learned about the physiology/mechanisms that underlie an adverse drug reaction’’
‘‘I know more about the side effects of several drugs’’
Getting to know Lareb (n = 1) ‘‘The existence of the pharmacovigilance center Lareb’’
Skills
Performing an ADR assessment (n = 10) ‘‘What happens if you have reported an ADR’’
‘‘I have learned how I can assess the causality of a suspected adverse drug reaction’’
Searching and assessing scientific literature (n = 9) ‘‘Searching for evidence-based literature regarding an adverse drug reaction’’
‘‘I also learned which sound information sources are available’’
Reporting an ADR (n = 8) ‘‘How and where to report an adverse drug reaction’’
Writing a scientific substantiated feedback letter
(n = 2)
‘‘To write a medical feedback letter that is short and concise’’
‘‘To write a clear pharmacological explanation of the ADR and to write a feedback
letter to the reporting physician’’
Themes are sorted based on Kirkpatrick’s hierarchy and were divided into three groups: intentions/attitudes, knowledge, and skills
ADR adverse drug reaction
T. Schutte et al.
an ADR reporting assignment [30] or a lecture, on stu-
dents’ pharmacovigilance skills. Future research should
also focus on the long-term effects of innovative pharma-
covigilance projects on ADR reporting.
Acknowledgements The authors would like to thank Mrs. D.W.M.
Pijnenburg (Pharmacist, The Netherlands Pharmacovigilance Centre
Lareb) for her help in rating the student assessments; J.J. Sikkens,
MSc, (Department of Internal Medicine, Pharmacotherapy Section,
VUmc, Amsterdam, The Netherlands) for his help with the statistical
analysis; Mrs. S. Groenland, Mrs. S. de Boer and Mrs. L. van Gastel
(VUmc School of Medical Sciences, Amsterdam, The Netherlands;
student-run pharmacovigilance programme and SRC coordinators);
all previous contributors to the LC-SRC project in VUmc; and all
students participating in the student-run pharmacovigilance
programme.
Compliance with Ethical Standards
Funding No sources of funding were used to assist in the preparation
of this study.
Conflicts of interest Tim Schutte, Jelle Tichelaar, Michael O.
Reumerman, Rike van Eekeren, Lea`n Rolfes, Euge`ne P. van Puijen-
broek, Milan C. Richir, and Michiel A. van Agtmael have no conflicts
of interest that are directly relevant to the content of this study.
Ethical Approval See ethical aspects section in Methods.
Open Access This article is distributed under the terms of the
Creative Commons Attribution-NonCommercial 4.0 International
License (http://creativecommons.org/licenses/by-nc/4.0/), which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided you give appropriate credit to the original
author(s) and the source, provide a link to the Creative Commons
license, and indicate if changes were made.
References
1. Sultana J, Cutroneo P, Trifiro G. Clinical and economic burden of
adverse drug reactions. J Pharmacol Pharmacother. 2013;4(Suppl
1):S73–7.
2. Gyllensten H, Rehnberg C, Jonsson AK, Petzold M, Carlsten A,
Andersson Sundell K. Cost of illness of patient-reported adverse
drug events: a population-based cross-sectional survey. BMJ
Open. 2013;3(6):pii e002574.
3. Molokhia M, Tanna S, Bell D. Improving reporting of adverse
drug reactions: systematic review. Clin Epidemiol. 2009;1:75–92.
4. Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley
TJ, et al. Adverse drug reactions as cause of admission to hos-
pital: prospective analysis of 18,820 patients. BMJ.
2004;329(7456):15–9.
5. Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK.
Adverse drug reactions. BMJ. 1998;316(7140):1295–8.
6. Martin K, Begaud B, Latry P, Miremont-Salame G, Fourrier A,
Moore N. Differences between clinical trials and postmarketing
use. Br J Clin Pharmacol. 2004;57(1):86–92.
7. Miguel A, Azevedo LF, Lopes F, Freitas A, Pereira AC.
Methodologies for the detection of adverse drug reactions:
comparison of hospital databases, chart review and spontaneous
reporting. Pharmacoepidemiol Drug Saf. 2013;22(1):98–102.
8. Safety monitoring of medicinal products. Guidelines for setting
up and running a pharmacovigilance centre. Uppsala: The Upp-
sala Monitoring Centre, WHO Collaborating Centre for Interna-
tional Drug Monitoring; 2011.
9. Backstrom M, Mjorndal T, Dahlqvist R. Under-reporting of
serious adverse drug reactions in Sweden. Pharmacoepidemiol
Drug Saf. 2004;13(7):483–7.
10. Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a
systematic review. Drug Saf. 2006;29(5):385–96.
11. Lopez-Gonzalez E, Herdeiro MT, Figueiras A. Determinants of
under-reporting of adverse drug reactions: a systematic review.
Drug Saf. 2009;32(1):19–31.
12. Schutte T, Tichelaar J, Reumerman MO, van Eekeren R, Riss-
mann R, Kramers C, et al. Pharmacovigilance skills, knowledge
and attitudes in our future doctors: a nationwide study in The
Netherlands. Basic Clin Pharmacol Toxicol. doi:10.1111/bcpt.
12712. (Epub 24 Nov 2016)
13. Gavaza P, Bui B. Pharmacy students’ attitudes toward reporting
serious adverse drug events. Am J Pharm Educ. 2012;76(10):194.
14. Elkalmi RM, Hassali MA, Ibrahim MI, Widodo RT, Efan QM,
Hadi MA. Pharmacy students’ knowledge and perceptions about
pharmacovigilance in Malaysian public universities. Am J Pharm
Educ. 2011;75(5):96.
15. Pagotto C, Varallo F, Mastroianni P. Impact of educational
interventions on adverse drug events reporting. Int J Technol
Assess Health Care. 2013;29(4):410–7.
16. Rosebraugh CJ, Tsong Y, Zhou F, Chen M, Mackey AC, Flowers
C, et al. Improving the quality of adverse drug reaction reporting
by 4th-year medical students. Pharmacoepidemiol Drug Saf.
2003;12(2):97–101.
17. Durrieu G, Hurault C, Bongard V, Damase-Michel C, Montastruc
JL. Perception of risk of adverse drug reactions by medical stu-
dents: influence of a 1 year pharmacological course. Br J Clin
Pharmacol. 2007;64(2):233–6.
18. Gerritsen R, Faddegon H, Dijkers F, van Grootheest K, van
Puijenbroek E. Effectiveness of pharmacovigilance training of
general practitioners: a retrospective cohort study in the Nether-
lands comparing two methods. Drug Saf. 2011;34(9):755–62.
19. Issenberg SB, McGaghie WC. Clinical skills training–practice
makes perfect. Med Educ. 2002;36(3):210–1.
20. Schutte T, Tichelaar J, Dekker RS, van Agtmael MA, de Vries
TP, Richir MC. Learning in student-run clinics: a systematic
review. Med Educ. 2015;49(3):249–63.
21. Dekker RS, Schutte T, Tichelaar J, Thijs A, van Agtmael MA, de
Vries TP, et al. A novel approach to teaching pharmacothera-
peutics–feasibility of the learner-centered student-run clinic. Eur
J Clin Pharmacol. 2015;71(11):1381–7.
22. Schutte T, Tichelaar J, van Agtmael M. Learning to prescribe in a
student-run clinic. Med Teach. 2016;38(4):425.
23. Gavaza P, Brown CM, Lawson KA, Rascati KL, Wilson JP,
Steinhardt M. Influence of attitudes on pharmacists’ intention to
report serious adverse drug events to the Food and Drug
Administration. Br J Clin Pharmacol. 2011;72(1):143–52.
24. Gavaza P, Brown CM, Lawson KA, Rascati KL, Wilson JP,
Steinhardt M. Texas pharmacists’ knowledge of reporting serious
adverse drug events to the Food and Drug Administration. J Am
Pharm Assoc (2003). 2011;51(3):397–403.
25. Kirkpatrick DI. Evaluation of training. In: Craig RL, Bittel,
LR (eds). Training and Development Handbook. New York:
McGraw-Hill; 1976.
26. WHO essential medicine list, 2015. Geneva: World Health
Organization; 2015.
27. Kusurkar RA, Croiset G, Ten Cate TJ. Twelve tips to stimulate
intrinsic motivation in students through autonomy-supportive
classroom teaching derived from self-determination theory. Med
Teach. 2011;33(12):978–82.
Feasibility and Educational Value of a Student-Run PV Programme
28. Schutte T, Tichelaar J, Dekker RS, Thijs A, de Vries TPGM,
Kusurkar RA, et al. Motivation and competence of participants in
a learner-centered student-run clinic: an exploratory pilot study.
BMC Med Educ. 2017. doi:10.1186/s12909-017-0856-9.
29. WHO Collaborating Centre for Pharmacovigilance in Education
and Patient Reporting. http://www.who.int/medicines/areas/
quality_safety/safety_efficacy/collab-centres-netherlands/, http://
www.lareb.nl/whocc?lang=en-GB. Accessed 7 Jan 2017.
30. van Eekeren R, van der Horst P, Hut F, van Grootheest K. Leer
studenten bijwerkingen herkennen. Medisch Contact.
2014;04:150–4.
T. Schutte et al.
